Table 1 Patient Characteristics
Cilengitide + Gemcitabine n = 46 | Gemcitabine n = 43 | Total n = 89 | ||
|---|---|---|---|---|
Age, years | Median | 68 | 66 | 67 |
Range | 40–80 | 56–80 | 40–80 | |
Gender (n, %) | Male | 26 (57%) | 18 (42%) | 44 (49%) |
Female | 20 (43%) | 25 (58%) | 45 (51%) | |
Stage | III | 3 (7%) | 4 (9%) | 7 (8%) |
IV | 3 (7%) | 1 (2%) | 4 (4%) | |
IVa | 3 (7%) | 4 (9%) | 7 (8%) | |
IVb | 37 (80%) | 34 (79%) | 71 (80%) | |
KP score at screening | 70 | 3 (7%) | 2 (5%) | 5 (6%) |
80 | 19 (41%) | 18 (42%) | 37 (42%) | |
90 | 18 (39%) | 17 (40%) | 35 (40%) | |
100 | 6 (13%) | 6 (14%) | 12 (13%) |